603658 安图生物
已收盘 02-27 15:00:00
资讯
新帖
简况
安图生物（603658）披露公司及全资子公司获得医疗器械注册证的公告，2月24日股价上涨0.3%
证券之星 · 02-24
安图生物（603658）披露公司及全资子公司获得医疗器械注册证的公告，2月24日股价上涨0.3%
10分钟股价涨超10%！多家上市公司称已具备尼帕病毒检测能力
21世纪经济报道 · 01-27
10分钟股价涨超10%！多家上市公司称已具备尼帕病毒检测能力
安图生物（603658）披露使用闲置募集资金进行现金管理赎回及进展，1月12日股价上涨0.78%
证券之星 · 01-12
安图生物（603658）披露使用闲置募集资金进行现金管理赎回及进展，1月12日股价上涨0.78%
每周股票复盘：安图生物（603658）获19项医疗器械注册证
证券之星 · 01-02
每周股票复盘：安图生物（603658）获19项医疗器械注册证
安图生物（603658）披露拟使用闲置募集资金进行现金管理，12月9日股价下跌0.86%
证券之星 · 2025-12-09
安图生物（603658）披露拟使用闲置募集资金进行现金管理，12月9日股价下跌0.86%
安图生物（603658）披露公司及子公司获得医疗器械注册证，12月2日股价下跌1.23%
证券之星 · 2025-12-02
安图生物（603658）披露公司及子公司获得医疗器械注册证，12月2日股价下跌1.23%
安图生物(603658.SH)及子公司获得医疗器械注册证
智通财经 · 2025-12-02
安图生物(603658.SH)及子公司获得医疗器械注册证
安图生物（603658）披露公司及全资子公司获得医疗器械注册证，11月27日股价下跌0.35%
证券之星 · 2025-11-27
安图生物（603658）披露公司及全资子公司获得医疗器械注册证，11月27日股价下跌0.35%
安图生物(603658.SH)及子公司取得多项医疗器械注册证
智通财经 · 2025-11-27
安图生物(603658.SH)及子公司取得多项医疗器械注册证
每周股票复盘：安图生物（603658）取消监事会设职工代表董事
证券之星 · 2025-11-16
每周股票复盘：安图生物（603658）取消监事会设职工代表董事
安图生物（603658）披露拟取消监事会并设职工代表董事，11月06日股价上涨0.71%
证券之星 · 2025-11-06
安图生物（603658）披露拟取消监事会并设职工代表董事，11月06日股价上涨0.71%
安图生物（603658）披露股份回购内部控制制度修订公告，10月31日股价上涨1.37%
证券之星 · 2025-10-31
安图生物（603658）披露股份回购内部控制制度修订公告，10月31日股价上涨1.37%
安图生物(603658)9月30日股东户数3.4万户，较上期减少0.58%
证券之星 · 2025-10-30
安图生物(603658)9月30日股东户数3.4万户，较上期减少0.58%
每周股票复盘：安图生物（603658）闲置募资赎回获益13.02万元
证券之星 · 2025-10-26
每周股票复盘：安图生物（603658）闲置募资赎回获益13.02万元
安图生物（603658）披露使用闲置募集资金进行现金管理赎回情况，10月20日股价下跌0.18%
证券之星 · 2025-10-20
安图生物（603658）披露使用闲置募集资金进行现金管理赎回情况，10月20日股价下跌0.18%
每周股票复盘：安图生物（603658）安图科技子公司完成证照变更
证券之星 · 2025-10-19
每周股票复盘：安图生物（603658）安图科技子公司完成证照变更
安图生物（603658）披露全资子公司完成医疗器械及药品经营许可证变更，10月13日股价下跌1.54%
证券之星 · 2025-10-13
安图生物（603658）披露全资子公司完成医疗器械及药品经营许可证变更，10月13日股价下跌1.54%
安图生物(603658.SH)及全资子公司获得医疗器械注册证
智通财经 · 2025-09-29
安图生物(603658.SH)及全资子公司获得医疗器械注册证
每周股票复盘：安图生物（603658）将召开2025年半年度业绩说明会
证券之星 · 2025-09-14
每周股票复盘：安图生物（603658）将召开2025年半年度业绩说明会
太平洋：给予安图生物买入评级
证券之星 · 2025-09-09
太平洋：给予安图生物买入评级
加载更多
公司概况
公司名称：
郑州安图生物工程股份有限公司
所属行业：
医药制造业
上市日期：
2016-09-01
主营业务：
郑州安图生物工程股份有限公司的主营业务是体外诊断试剂和仪器的研发、制造、整合及服务。公司的主要产品是免疫类诊断试剂、微生物检测试剂、分子诊断检测试剂、生化检测试剂、质谱检测试剂、免疫检测仪器、微生物检测仪器、分子检测仪器、生化检测仪器、质谱检测仪器、检验辅助仪器。
发行价格：
14.58
{"stockData":{"symbol":"603658","market":"SH","secType":"STK","nameCN":"安图生物","latestPrice":36.31,"timestamp":1772175600000,"preClose":36.18,"halted":0,"volume":1613570,"delay":0,"changeRate":0.0036,"floatShares":571000000,"shares":571000000,"eps":1.9212,"marketStatus":"已收盘","change":0.13,"latestTime":"02-27 15:00:00","open":36.17,"high":36.37,"low":36.1,"amount":58543900,"amplitude":0.0075,"askPrice":36.31,"askSize":81,"bidPrice":36.3,"bidSize":101,"shortable":0,"etf":0,"ttmEps":1.9212,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1772415000000},"marketStatusCode":5,"adr":0,"adjPreClose":36.18,"symbolType":"stock","openAndCloseTimeList":[[1772155800000,1772163000000],[1772168400000,1772175600000]],"highLimit":39.8,"lowLimit":32.56,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":571424768,"isCdr":false,"pbRate":2.37,"roa":"--","peRate":18.899646,"roe":"9.86%","epsLYR":2.07,"committee":-0.344992,"marketValue":20748000000,"turnoverRate":0.0028,"status":0,"nextConnectDate":"根据港交所公布的数据，今日已停止北向交易，下一个交易日为北京时间 2026-03-02。","floatMarketCap":20748000000},"requestUrl":"/m/hq/s/603658","defaultTab":"news","newsList":[{"id":"2613229792","title":"安图生物（603658）披露公司及全资子公司获得医疗器械注册证的公告，2月24日股价上涨0.3%","url":"https://stock-news.laohu8.com/highlight/detail?id=2613229792","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2613229792?lang=zh_cn&edition=full","pubTime":"2026-02-24 18:22","pubTimestamp":1771928540,"startTime":"0","endTime":"0","summary":"截至2026年2月24日收盘，安图生物报收于36.29元，较前一交易日上涨0.3%，最新总市值为207.37亿元。该股当日开盘36.24元，最高36.37元，最低36.1元，成交额达6235.5万元，换手率为0.3%。近日，郑州安图生物工程股份有限公司及全资子公司安图实验仪器（郑州）有限公司收到河南省药品监督管理局颁发的医疗器械注册证。上述产品用于体外定量检测人血清或血浆中相应物质含量，或用于对液体中细胞进行多参数快速定量分析。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026022400036534.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","09997","603658","159883","BK1222","BK1574","BK1583","BK1100","BK0046","09996"],"gpt_icon":0},{"id":"2606245208","title":"10分钟股价涨超10%！多家上市公司称已具备尼帕病毒检测能力","url":"https://stock-news.laohu8.com/highlight/detail?id=2606245208","media":"21世纪经济报道","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2606245208?lang=zh_cn&edition=full","pubTime":"2026-01-27 14:12","pubTimestamp":1769494320,"startTime":"0","endTime":"0","summary":"1月27日，博晖创新盘中突然拉升翻红，10分钟涨超10%，截至13：30，涨8.34%，报7.79元/股。消息面上，博晖创新当日发文称，公司已自主研发了尼帕病毒核酸检测试剂盒。 2024年年报显示，博晖创新HPV检测产品、微量元素检测产品、质谱相关检测产品营收居前，分别占总营收的12.89%、4.71%、10.71%，尼帕病毒检测产品未见上榜。","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/bxjj/2026-01-27/doc-inhitntx9835883.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/bxjj/2026-01-27/doc-inhitntx9835883.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0132","BK0042","300318","MNDmain","BK0028","300639","BK0048","BK0239","BK0046","BK0251","603658"],"gpt_icon":0},{"id":"2602422546","title":"安图生物（603658）披露使用闲置募集资金进行现金管理赎回及进展，1月12日股价上涨0.78%","url":"https://stock-news.laohu8.com/highlight/detail?id=2602422546","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2602422546?lang=zh_cn&edition=full","pubTime":"2026-01-12 22:37","pubTimestamp":1768228629,"startTime":"0","endTime":"0","summary":"截至2026年1月12日收盘，安图生物报收于37.39元，较前一交易日上涨0.78%，最新总市值为213.66亿元。该股当日开盘37.07元，最高37.61元，最低37.07元，成交额达1.66亿元，换手率为0.78%。本次现金管理不影响募投项目实施，不构成关联交易，且已履行董事会审议程序。最近12个月内公司累计使用闲置募集资金进行现金管理，尚未收回本金金额为160,000万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026011200037570.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0046","BK0239","603658"],"gpt_icon":0},{"id":"2600036845","title":"每周股票复盘：安图生物（603658）获19项医疗器械注册证","url":"https://stock-news.laohu8.com/highlight/detail?id=2600036845","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2600036845?lang=zh_cn&edition=full","pubTime":"2026-01-02 02:35","pubTimestamp":1767292512,"startTime":"0","endTime":"0","summary":"截至2025年12月26日收盘，安图生物报收于36.16元，较上周的36.2元下跌0.11%。本周，安图生物12月26日盘中最高价报36.25元。安图生物当前最新总市值202.4亿元，在医疗器械板块市值排名10/127，在两市A股市值排名975/5181。本周关注点公司公告汇总：安图生物及子公司获19项医疗器械注册证。公司公告汇总：子公司通过高新技术企业重新认定，2025年起三年享15%所得税优惠。2025年度已按该税率预缴企业所得税，本次认定不影响公司2025年度财务数据。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026010200000600.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["159883","603658","BK1574","BK1222","BK0239","09996","BK1100","BK1583","BK0046","09997"],"gpt_icon":0},{"id":"2590250344","title":"安图生物（603658）披露拟使用闲置募集资金进行现金管理，12月9日股价下跌0.86%","url":"https://stock-news.laohu8.com/highlight/detail?id=2590250344","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590250344?lang=zh_cn&edition=full","pubTime":"2025-12-09 22:11","pubTimestamp":1765289496,"startTime":"0","endTime":"0","summary":"截至2025年12月9日收盘，安图生物报收于35.67元，较前一交易日下跌0.86%，最新总市值为203.83亿元。该股当日开盘35.91元，最高36.02元，最低35.64元，成交额达6655.78万元，换手率为0.33%。公司近日发布公告称，拟使用不超过1.4亿元可转债闲置募集资金和不超过15.4亿元非公开发行股票闲置募集资金进行现金管理，投资于结构性存款、大额存单、国债逆回购等安全性高、流动性好的保本型产品，期限不超过12个月，资金可滚动使用，不影响募投项目实施。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025120900040325.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603658","BK0046","BK0239"],"gpt_icon":0},{"id":"2588501059","title":"安图生物（603658）披露公司及子公司获得医疗器械注册证，12月2日股价下跌1.23%","url":"https://stock-news.laohu8.com/highlight/detail?id=2588501059","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588501059?lang=zh_cn&edition=full","pubTime":"2025-12-02 22:12","pubTimestamp":1764684773,"startTime":"0","endTime":"0","summary":"截至2025年12月2日收盘，安图生物报收于36.07元，较前一交易日下跌1.23%，最新总市值为206.11亿元。近日，安图生物发布公告称，郑州安图生物工程股份有限公司及子公司思昆生物、郑州标源近日获得多项医疗器械注册证，涉及基因测序仪、中性粒细胞明胶酶相关脂质运载蛋白检测试剂盒、壳多糖酶3样蛋白1检测试剂盒、抗U1核糖核蛋白抗体IgG检测试剂盒、高血压标志物质控品及骨代谢标志物质控品。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025120200039463.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0046","BK1100","09996","BK1574","BK1583","09997","BK1222","603658","159883","BK0239"],"gpt_icon":0},{"id":"2588394039","title":"安图生物(603658.SH)及子公司获得医疗器械注册证","url":"https://stock-news.laohu8.com/highlight/detail?id=2588394039","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588394039?lang=zh_cn&edition=full","pubTime":"2025-12-02 17:43","pubTimestamp":1764668613,"startTime":"0","endTime":"0","summary":"智通财经APP讯，安图生物(603658.SH)发布公告，公司及全资子公司郑州思昆生物工程有限公司(简称“思昆生物”)、二级子公司郑州标源生物科技有限公司(简称“郑州标源”)分别于近日收到国家药品监督管理局、河南省药品监督管理局颁发的医疗器械注册证。上述医疗器械注册证的取得进一步丰富了公司产品菜单，不断满足市场需求，是对公司现有检测产品的有效补充，可以逐步提高公司产品的整体竞争力，短期内对公司的经营业绩影响较小。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1376576.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1222","BK0046","BK0239","603658","BK1583","BK1574","09997","159883","BK1100","09996"],"gpt_icon":0},{"id":"2586722558","title":"安图生物（603658）披露公司及全资子公司获得医疗器械注册证，11月27日股价下跌0.35%","url":"https://stock-news.laohu8.com/highlight/detail?id=2586722558","media":"证券之星","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586722558?lang=zh_cn&edition=full","pubTime":"2025-11-27 22:12","pubTimestamp":1764252739,"startTime":"0","endTime":"0","summary":"截至2025年11月27日收盘，安图生物报收于36.75元，较前一交易日下跌0.35%，最新总市值为210亿元。该股当日开盘36.88元，最高37.0元，最低36.61元，成交额达6717.37万元，换手率为0.32%。注册证有效期均为5年。上述产品注册证的取得将丰富公司产品线，短期内对公司经营业绩影响较小。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025112700038344.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["09996","BK0046","BK0239","BK1574","BK1583","BK1100","09997","BK1222","603658","159883"],"gpt_icon":0},{"id":"2586243595","title":"安图生物(603658.SH)及子公司取得多项医疗器械注册证","url":"https://stock-news.laohu8.com/highlight/detail?id=2586243595","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586243595?lang=zh_cn&edition=full","pubTime":"2025-11-27 16:57","pubTimestamp":1764233868,"startTime":"0","endTime":"0","summary":"智通财经APP讯，安图生物(603658.SH)发布公告，公司及全资子公司安图实验仪器(郑州)有限公司(简称“安图仪器”)于近日收到河南省药品监督管理局颁发的多项医疗器械注册证。上述医疗器械注册证的取得进一步丰富了公司产品菜单，不断满足市场需求，是对公司现有检测产品的有效补充，可以逐步提高公司产品的整体竞争力，短期内对公司的经营业绩影响较小。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1374476.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["09996","BK1574","159883","603658","BK1222","BK0046","BK0239","BK1583","BK1100","09997"],"gpt_icon":0},{"id":"2583654623","title":"每周股票复盘：安图生物（603658）取消监事会设职工代表董事","url":"https://stock-news.laohu8.com/highlight/detail?id=2583654623","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2583654623?lang=zh_cn&edition=full","pubTime":"2025-11-16 04:48","pubTimestamp":1763239690,"startTime":"0","endTime":"0","summary":"截至2025年11月14日收盘，安图生物报收于39.33元，较上周的38.61元上涨1.86%。本周关注点公司公告汇总：安图生物股东大会通过取消监事会、设置职工代表董事的议案。公司公告汇总：安图生物2025年第二次临时股东大会表决结果合法有效，无否决议案。郑州安图生物工程股份有限公司于2025年11月14日召开职工代表大会，选举刘微女士为公司第五届董事会职工代表董事。刘微女士任期自股东大会决议生效之日起三年，与第五届董事会任期一致。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025111600001413.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0046","BK0239","603658"],"gpt_icon":0},{"id":"2581094509","title":"安图生物（603658）披露拟取消监事会并设职工代表董事，11月06日股价上涨0.71%","url":"https://stock-news.laohu8.com/highlight/detail?id=2581094509","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2581094509?lang=zh_cn&edition=full","pubTime":"2025-11-06 22:27","pubTimestamp":1762439240,"startTime":"0","endTime":"0","summary":"截至2025年11月6日收盘，安图生物报收于38.38元，较前一交易日上涨0.71%，最新总市值为219.31亿元。该股当日开盘38.02元，最高38.48元，最低38.02元，成交额达7366.46万元，换手率为0.34%。近日，郑州安图生物工程股份有限公司发布2025年第二次临时股东大会会议材料，宣布拟修订《公司章程》，取消监事会并设置职工代表董事，原由监事会行使的职权将由董事会审计委员会履行。职工代表董事将由职工代表大会民主选举产生，且不领取董事津贴。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025110600038257.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","603658","BK0046"],"gpt_icon":0},{"id":"2579932924","title":"安图生物（603658）披露股份回购内部控制制度修订公告，10月31日股价上涨1.37%","url":"https://stock-news.laohu8.com/highlight/detail?id=2579932924","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2579932924?lang=zh_cn&edition=full","pubTime":"2025-10-31 22:27","pubTimestamp":1761920852,"startTime":"0","endTime":"0","summary":"近日，郑州安图生物工程股份有限公司发布《股份回购内部控制制度》公告。公告显示，公司制定股份回购内部控制制度，旨在规范股份回购行为，提升公司治理水平。公司不得在重大事项敏感期回购股份，回购期间需定期披露进展。已回购股份用于注销的，应在3年内注销；用于转让的，须在披露回购结果12个月后方可出售，且出售需遵守集中竞价交易限制。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025103100049766.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0046","603658","BK0239"],"gpt_icon":0},{"id":"2579188341","title":"安图生物(603658)9月30日股东户数3.4万户，较上期减少0.58%","url":"https://stock-news.laohu8.com/highlight/detail?id=2579188341","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2579188341?lang=zh_cn&edition=full","pubTime":"2025-10-30 17:23","pubTimestamp":1761816181,"startTime":"0","endTime":"0","summary":"证券之星消息，近日安图生物披露，截至2025年9月30日公司股东户数为3.4万户，较6月30日减少197.0户，减幅为0.58%。在医疗器械行业个股中，安图生物股东户数高于行业平均水平，截至9月30日，医疗器械行业平均股东户数为2.21万户。从股价来看，2025年6月30日至2025年9月30日，安图生物区间涨幅为4.53%，在此期间股东户数减少197.0户，减幅为0.58%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025103000032751.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0046","603658"],"gpt_icon":0},{"id":"2578050241","title":"每周股票复盘：安图生物（603658）闲置募资赎回获益13.02万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2578050241","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2578050241?lang=zh_cn&edition=full","pubTime":"2025-10-26 03:21","pubTimestamp":1761420070,"startTime":"0","endTime":"0","summary":"截至2025年10月24日收盘，安图生物报收于38.83元，较上周的38.32元上涨1.33%。本周，安图生物10月22日盘中最高价报39.09元。公司公告汇总安图生物于2025年10月20日公告，使用非公开发行股票闲置募集资金购买的兴业银行可转让单位大额存单已到期赎回。安图生物于2025年10月24日公告，收到招商证券《关于更换保荐代表人的函》。原保荐代表人刘海燕因职务调动不再履职，招商证券指派张茜自2025年10月22日起接替其工作。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025102600000725.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0046","603658"],"gpt_icon":0},{"id":"2576863450","title":"安图生物（603658）披露使用闲置募集资金进行现金管理赎回情况，10月20日股价下跌0.18%","url":"https://stock-news.laohu8.com/highlight/detail?id=2576863450","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2576863450?lang=zh_cn&edition=full","pubTime":"2025-10-20 22:43","pubTimestamp":1760971391,"startTime":"0","endTime":"0","summary":"近日，郑州安图生物工程股份有限公司发布公告，称公司使用非公开发行股票闲置募集资金购买的兴业银行可转让单位大额存单已到期赎回。公司于2024年12月11日召开董事会及监事会，审议通过使用不超过1.7亿元公开发行可转债闲置募集资金和不超过17亿元非公开发行股票闲置募集资金进行现金管理的议案，额度内资金可滚动使用，期限不超过12个月。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025102000032613.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603658","BK0046","BK0239"],"gpt_icon":0},{"id":"2576263041","title":"每周股票复盘：安图生物（603658）安图科技子公司完成证照变更","url":"https://stock-news.laohu8.com/highlight/detail?id=2576263041","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2576263041?lang=zh_cn&edition=full","pubTime":"2025-10-19 04:41","pubTimestamp":1760820068,"startTime":"0","endTime":"0","summary":"截至2025年10月17日收盘，安图生物报收于38.32元，较上周的39.0元下跌1.74%。本周，安图生物10月16日盘中最高价报38.99元。本周关注点公司公告汇总：全资子公司安图科技完成医疗器械及药品经营许可证变更登记。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025101900000985.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0046","603658","BK0239"],"gpt_icon":0},{"id":"2575003624","title":"安图生物（603658）披露全资子公司完成医疗器械及药品经营许可证变更，10月13日股价下跌1.54%","url":"https://stock-news.laohu8.com/highlight/detail?id=2575003624","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2575003624?lang=zh_cn&edition=full","pubTime":"2025-10-13 22:38","pubTimestamp":1760366303,"startTime":"0","endTime":"0","summary":"截至2025年10月13日收盘，安图生物报收于38.4元，较前一交易日下跌1.54%，最新总市值为219.43亿元。该股当日开盘38.44元，最高38.64元，最低38.22元，成交额达1.04亿元，换手率为0.48%。公司近日发布公告称，其全资子公司郑州安图科技发展有限公司已取得郑州经济技术开发区市场监督管理局换发的《医疗器械经营许可证》及河南省药品监督管理局换发的《药品经营许可证》。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025101300025430.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1574","BK0046","BK0239","BK1222","09997","BK1100","603658","BK1583","09996","159883"],"gpt_icon":0},{"id":"2571827386","title":"安图生物(603658.SH)及全资子公司获得医疗器械注册证","url":"https://stock-news.laohu8.com/highlight/detail?id=2571827386","media":"智通财经","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2571827386?lang=zh_cn&edition=full","pubTime":"2025-09-29 17:25","pubTimestamp":1759137927,"startTime":"0","endTime":"0","summary":"智通财经APP讯，安图生物(603658.SH)发布公告，公司及全资子公司安图实验仪器(郑州)有限公司(简称“安图仪器”)于近日收到国家药品监督管理局、河南省药品监督管理局颁发的医疗器械注册证。上述医疗器械注册证的取得进一步丰富了公司产品菜单，不断满足市场需求，是对公司现有检测产品的有效补充，可以逐步提高公司产品的整体竞争力，短期内对公司的经营业绩影响较小。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1350641.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1583","BK0239","BK0046","09997","BK1100","159883","BK1574","603658","BK1222","09996"],"gpt_icon":0},{"id":"2567136973","title":"每周股票复盘：安图生物（603658）将召开2025年半年度业绩说明会","url":"https://stock-news.laohu8.com/highlight/detail?id=2567136973","media":"证券之星","labels":["conferences"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2567136973?lang=zh_cn&edition=full","pubTime":"2025-09-14 04:55","pubTimestamp":1757796910,"startTime":"0","endTime":"0","summary":"截至2025年9月12日收盘，安图生物报收于41.13元，较上周的40.55元上涨1.43%。本周，安图生物9月9日盘中最高价报42.37元。本周关注点公司公告汇总：安图生物将于2025年9月22日召开半年度业绩说明会，投资者可提前提交问题。公司已于2025年8月22日发布2025年半年度报告。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025091400001143.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603658","BK0046","BK0239"],"gpt_icon":0},{"id":"2566656147","title":"太平洋：给予安图生物买入评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2566656147","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2566656147?lang=zh_cn&edition=full","pubTime":"2025-09-09 08:33","pubTimestamp":1757378022,"startTime":"0","endTime":"0","summary":"太平洋证券股份有限公司谭紫媚,李啸岩近期对安图生物进行研究并发布了研究报告《安图生物：化学发光业务改善，盈利能力维持稳定》，给予安图生物买入评级。同时，公司对测序仪同样寄予厚望，预计近期获证。维持“买入”评级。最新盈利预测明细如下：该股最近90天内共有10家机构给出评级，买入评级9家，增持评级1家；过去90天内机构目标均价为51.38。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025090900007110.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["601099","603658"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1772231734919,"stockEarnings":[{"period":"1week","weight":0.0036},{"period":"1month","weight":-0.0281},{"period":"3month","weight":-0.0071},{"period":"6month","weight":-0.105},{"period":"1year","weight":-0.1015},{"period":"ytd","weight":0.0251}],"compareEarnings":[{"period":"1week","weight":0.0198},{"period":"1month","weight":0.0028},{"period":"3month","weight":0.0705},{"period":"6month","weight":0.079},{"period":"1year","weight":0.2287},{"period":"ytd","weight":0.0489}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"郑州安图生物工程股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"33981人(较上一季度减少0.58%)","perCapita":"16816股","listingDate":"2016-09-01","address":"河南省郑州市管城回族区经济技术开发区经北一路87号","registeredCapital":"57142万元","survey":" 郑州安图生物工程股份有限公司的主营业务是体外诊断试剂和仪器的研发、制造、整合及服务。公司的主要产品是免疫类诊断试剂、微生物检测试剂、分子诊断检测试剂、生化检测试剂、质谱检测试剂、免疫检测仪器、微生物检测仪器、分子检测仪器、生化检测仪器、质谱检测仪器、检验辅助仪器。","listedPrice":14.58},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"安图生物(603658)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供安图生物(603658)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"安图生物,603658,安图生物股票,安图生物股票老虎,安图生物股票老虎国际,安图生物行情,安图生物股票行情,安图生物股价,安图生物股市,安图生物股票价格,安图生物股票交易,安图生物股票购买,安图生物股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"安图生物(603658)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供安图生物(603658)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}